Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial. [electronic resource]
Producer: 20130531Description: 1415-21 p. digitalISSN:- 1527-7755
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Squamous Cell -- genetics
- Chemoradiotherapy -- adverse effects
- Cisplatin -- administration & dosage
- Disease-Free Survival
- Drug Administration Schedule
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Exanthema -- chemically induced
- Female
- Head and Neck Neoplasms -- genetics
- Humans
- In Situ Hybridization, Fluorescence
- Male
- Pain -- chemically induced
- Quinazolines -- administration & dosage
- Remission Induction
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.